{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:13:10Z","timestamp":1794654790703,"version":"4.9.1"},"reference-count":127,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-65-00027"],"award-info":[{"award-number":["24-65-00027"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by the presence of various serum autoantibodies and multi-system effects, predominantly affecting young female patients. The pathogenesis of SLE involves a combination of genetic factors, environmental triggers, and pathogen invasions that disrupt immune cell activation, leading to the release of autoantibodies and chronic inflammation. Mitochondria, as the primary cellular powerhouses, play a crucial role in SLE development through their control of energy generation, reactive oxygen species (ROS) production, and cellular apoptotic pathways. Dysregulation of mitochondrial structure and function can contribute to the immune dysregulation, oxidative stress, and inflammation seen in SLE. Recent research has highlighted the impact of mitochondrial dysfunction on various immune cells involved in SLE pathogenesis, such as T-lymphocytes, B-lymphocytes, neutrophils, and plasmacytoid dendritic cells. Mitochondrial dysfunction in these immune cells leads to increased ROS production, disrupted mitophagy, and alterations in energy metabolism, contributing to immune dysregulation and inflammation. Moreover, genetic variations in mitochondrial DNA (mtDNA) and abnormalities in mitochondrial dynamics have been linked to the pathogenesis of SLE, exacerbating oxidative stress and immune abnormalities. Targeting mitochondrial function has emerged as a promising therapeutic approach for SLE. Drugs such as sirolimus, N-acetylcysteine, coenzyme Q10, and metformin have shown potential in restoring mitochondrial homeostasis, reducing oxidative stress, and modulating immune responses in SLE. These agents have demonstrated efficacy in preclinical models and clinical studies by improving disease activity, reducing autoantibody titers, and ameliorating organ damage in SLE patients. In conclusion, this review underscores the critical role of mitochondria in the pathogenesis of SLE and the potential of targeting mitochondrial dysfunction as a novel therapeutic strategy for improving outcomes in SLE patients. Further investigation into the mechanisms underlying mitochondrial involvement in SLE and the development of targeted mitochondrial therapies hold promise for advancing SLE treatment and enhancing patient care.<\/jats:p>","DOI":"10.3390\/diseases12090226","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T03:49:46Z","timestamp":1727149786000},"page":"226","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-1320","authenticated-orcid":false,"given":"Anastasia V.","family":"Poznyak","sequence":"first","affiliation":[{"name":"Institute for Atherosclerosis Research, Osennyaya 4-1-207, 121609 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay A.","family":"Orekhov","sequence":"additional","affiliation":[{"name":"Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3920-7581","authenticated-orcid":false,"given":"Alexey V.","family":"Churov","sequence":"additional","affiliation":[{"name":"Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia"},{"name":"Russian Gerontology Clinical Research Centre, Institute on Aging Research, Pirogov Russian National Research Medical University, Russian Federation, 16 1st Leonova Street, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4665-2966","authenticated-orcid":false,"given":"Irina A.","family":"Starodubtseva","sequence":"additional","affiliation":[{"name":"Department of Polyclinic Therapy, N.N. Burdenko Voronezh State Medical University, 10 Studencheskaya Street, 394036 Voronezh, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7808-3454","authenticated-orcid":false,"given":"Dmitry F.","family":"Beloyartsev","sequence":"additional","affiliation":[{"name":"Vascular Surgery Department, A.V. Vishnevsky National Medical Research Center of Surgery, 27 Bolshaya Serpukhovskaya Street, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana I.","family":"Kovyanova","sequence":"additional","affiliation":[{"name":"Institute for Atherosclerosis Research, Osennyaya 4-1-207, 121609 Moscow, Russia"},{"name":"Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0312-3773","authenticated-orcid":false,"given":"Vasily N.","family":"Sukhorukov","sequence":"additional","affiliation":[{"name":"Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3318-4681","authenticated-orcid":false,"given":"Alexander N.","family":"Orekhov","sequence":"additional","affiliation":[{"name":"Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"ref_1","unstructured":"Justiz Vaillant, A.A., Goyal, A., and Varacallo, M. (2023, August 04). Systemic Lupus erythematosus, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535405\/."},{"key":"ref_2","unstructured":"Anaya, J.M., Shoenfeld, Y., Rojas-Villarraga, A., Levy, R.A., and Cervera, R. (2023, August 04). Systemic lupus erythematosus, Autoimmunity: From Bench to Bedside, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459474\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"i55","DOI":"10.1093\/rheumatology\/kew427","article-title":"Pathways leading to an immunological disease: Systemic lupus erythematosus","volume":"56","author":"Zharkova","year":"2017","journal-title":"Rheumatology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Accapezzato, D., Caccavale, R., Paroli, M.P., Gioia, C., Nguyen, B.L., Spadea, L., and Paroli, M. (2023). Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076578"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.13941.1","article-title":"Recent advances in the management of systemic lupus erythematosus","volume":"7","author":"Sciascia","year":"2018","journal-title":"F1000Research"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00296-023-05306-5","article-title":"Current treatment of systemic lupus erythematosus: A clinician\u2019s perspective","volume":"43","author":"Katarzyna","year":"2023","journal-title":"Rheumatol. Int."},{"key":"ref_7","unstructured":"Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2023, August 04). Molecular Biology of the Cell, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26894\/."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yu, R., Lendahl, U., Nist\u00e9r, M., and Zhao, J. (2020). Regulation of Mammalian Mitochondrial Dynamics: Opportunities and Challenges. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00374"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kowalczyk, P., Sulejczak, D., Kleczkowska, P., Bukowska-O\u015bko, I., Kucia, M., Popiel, M., Wietrak, E., Kramkowski, K., Wrzosek, K., and Kaczy\u0144ska, K. (2021). Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413384"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: Central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"dmm048912","DOI":"10.1242\/dmm.048912","article-title":"Mitochondrial function in development and disease","volume":"14","author":"Rossmann","year":"2021","journal-title":"Dis. Models Mech."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hayden, M.R. (2022). The Mighty Mitochondria Are Unifying Organelles and Metabolic Hubs in Multiple Organs of Obesity, Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes: An Observational Ultrastructure Study. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094820"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e34488","DOI":"10.7554\/eLife.34488","article-title":"Independent evolution of functionally exchangeable mitochondrial outer membrane import complexes","volume":"7","author":"Vitali","year":"2018","journal-title":"eLife"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Wu, Q., Tsai, H.I., Zhu, H., and Wang, D. (2022). The Entanglement between Mitochondrial DNA and Tumor Metastasis. Cancers, 14.","DOI":"10.3390\/cancers14081862"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Andrieux, P., Chevillard, C., Cunha-Neto, E., and Nunes, J.P.S. (2021). Mitochondria as a Cellular Hub in Infection and Inflammation. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111338"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/bs.enz.2019.08.004","article-title":"Mitochondrial DNA degradation: A quality control measure for mitochondrial genome maintenance and stress response","volume":"45","author":"Zhao","year":"2019","journal-title":"Enzymes"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.mad.2008.03.002","article-title":"Mitochondrial DNA repair in aging and disease","volume":"129","author":"Druzhyna","year":"2008","journal-title":"Mech. Ageing Dev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/nar\/gkad208","article-title":"Single-cell individual full-length mtDNA sequencing by iMiGseq uncovers unexpected heteroplasmy shifts in mtDNA editing","volume":"51","author":"Bi","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Parakatselaki, M.E., and Ladoukakis, E.D. (2021). mtDNA Heteroplasmy: Origin, Detection, Significance, and Evolutionary Consequences. Life, 11.","DOI":"10.3390\/life11070633"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Vona, R., Pallotta, L., Cappelletti, M., Severi, C., and Matarrese, P. (2021). The Impact of Oxidative Stress in Human Pathology: Focus on Gastrointestinal Disorders. Antioxidants, 10.","DOI":"10.3390\/antiox10020201"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.nbd.2014.01.001","article-title":"PGC-1\u03b1 regulation of mitochondrial degeneration in experimental diabetic neuropathy","volume":"64","author":"Choi","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.2174\/1381612820666140305224906","article-title":"Mitochondrial biogenesis: A therapeutic target for neurodevelopmental disorders and neurodegenerative diseases","volume":"20","author":"Uittenbogaard","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/CIRCRESAHA.112.265819","article-title":"Mitochondria and mitophagy: The yin and yang of cell death control","volume":"111","author":"Kubli","year":"2012","journal-title":"Circ. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/fca.12.58","article-title":"Mitochondrial membrane permeabilization and cell death during myocardial infarction: Roles of calcium and reactive oxygen species","volume":"8","author":"Webster","year":"2012","journal-title":"Future Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Li, Y., Li, S., and Wu, H. (2022). Ubiquitination-Proteasome System (UPS) and Autophagy Two Main Protein Degradation Machineries in Response to Cell Stress. Cells, 11.","DOI":"10.3390\/cells11050851"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/1570159X18666200522202319","article-title":"The Dawn of Mitophagy: What Do We Know by Now?","volume":"19","author":"Belousov","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Iorio, R., Celenza, G., and Petricca, S. (2021). Mitophagy: Molecular Mechanisms, New Concepts on Parkin Activation and the Emerging Role of AMPK\/ULK1 Axis. Cells, 11.","DOI":"10.3390\/cells11010030"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1080\/15548627.2021.1975914","article-title":"The multifaceted regulation of mitophagy by endogenous metabolites","volume":"18","author":"Zhang","year":"2022","journal-title":"Autophagy"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Venditti, P., and Di Meo, S. (2020). The Role of Reactive Oxygen Species in the Life Cycle of the Mitochondrion. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062173"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.toxrep.2017.05.008","article-title":"8-Hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in workers exposed to low-dose benzene","volume":"4","author":"Fenga","year":"2017","journal-title":"Toxicol. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"C221","DOI":"10.1152\/ajpcell.00140.2013","article-title":"Mitochondrial 8-oxoguanine glycosylase decreases mitochondrial fragmentation and improves mitochondrial function in H9C2 cells under oxidative stress conditions","volume":"306","author":"Gawlowski","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Elghzaly, A.A., Sun, C., Looger, L.L., Hirose, M., Salama, M., Khalil, N.M., Behiry, M.E., Hegazy, M.T., Hussein, M.A., and Salem, M.N. (2022). Genome-wide association study for systemic lupus erythematosus in an egyptian population. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.948505"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.semnephrol.2010.01.007","article-title":"Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis","volume":"30","author":"Ramos","year":"2010","journal-title":"Semin. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Becker, Y., Marcoux, G., Allaeys, I., Julien, A.S., Loignon, R.C., Benk-Fortin, H., Rollet-Labelle, E., Rauch, J., Fortin, P.R., and Boilard, E. (2019). Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01026"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Becker, Y., Loignon, R.C., Julien, A.S., Marcoux, G., Allaeys, I., L\u00e9vesque, T., Rollet-Labelle, E., Benk-Fortin, H., Cloutier, N., and Melki, I. (2019). Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-40900-3"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Jiao, Y., Yan, Z., and Yang, A. (2023). Mitochondria in innate immunity signaling and its therapeutic implications in autoimmune diseases. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1160035"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e49799","DOI":"10.15252\/embr.201949799","article-title":"Mitochondrial DNA in inflammation and immunity","volume":"21","author":"Riley","year":"2020","journal-title":"EMBO Rep."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zuo, Z., Jing, K., Wu, H., Wang, S., Ye, L., Li, Z., Yang, C., Pan, Q., Liu, W.J., and Liu, H.F. (2020). Mechanisms and Functions of Mitophagy and Potential Roles in Renal Disease. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00935"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Zhao, L., Hu, X., Xiao, F., Zhang, X., Zhao, L., and Wang, M. (2022). Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.929520"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.33549\/physiolres.935007","article-title":"\u201cDouble-edged sword\u201d effect of reactive oxygen species (ROS) in tumor development and carcinogenesis","volume":"72","author":"Zhao","year":"2023","journal-title":"Physiol. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/art.30353","article-title":"Calcium signaling in systemic lupus erythematosus T cells: A treatment target","volume":"63","author":"Kyttaris","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1007\/s10439-006-9179-4","article-title":"NFAT and NFkappaB activation in T lymphocytes: A model of differential activation of gene expression","volume":"34","author":"Fisher","year":"2006","journal-title":"Ann. Biomed. Eng."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Park, Y.J., Yoo, S.A., Kim, M., and Kim, W.U. (2020). The Role of Calcium-Calcineurin-NFAT Signaling Pathway in Health and Autoimmune Diseases. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00195"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/art.34502","article-title":"N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial","volume":"64","author":"Lai","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13063-023-07083-9","article-title":"Effects of N-acetylcysteine on systemic lupus erythematosus disease activity and its associated complications: A randomized double-blind clinical trial study","volume":"24","author":"Abbasifard","year":"2023","journal-title":"Trials"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Torres Acosta, M.A., Mambetsariev, N., Reyes Flores, C.P., Helmin, K.A., Liu, Q., Joudi, A.M., Morales-Nebreda, L., Gurkan, J., Cheng, K., and Abdala-Valencia, H. (2023). AMP-activated protein kinase is necessary for Treg cell functional adaptation to microenvironmental stress. bioRxiv.","DOI":"10.1101\/2023.11.29.568904"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Hurtado, C., Rojas-Gualdr\u00f3n, D.F., Urrego, R., Cashman, K., V\u00e1squez-Trespalacios, E.M., D\u00edaz-Coronado, J.C., Rojas, M., Jenks, S., V\u00e1squez, G., and Sanz, I. (2022). Altered B cell phenotype and CD27+ memory B cells are associated with clinical features and environmental exposure in Colombian systemic lupus erythematosus patients. Front. Med., 9.","DOI":"10.3389\/fmed.2022.950452"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1615\/CritRevImmunol.2018025213","article-title":"SLE-Associated Defects Promote Altered T Cell Function","volume":"37","author":"Crispin","year":"2017","journal-title":"Crit. Rev. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41420-021-00568-z","article-title":"IRF-8\/miR-451a regulates M-MDSC differentiation via the AMPK\/mTOR signal pathway during lupus development","volume":"7","author":"Shi","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_52","first-page":"73ra20","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Caielli","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/ar3345","article-title":"Neutrophils and interferon-\u03b1-producing cells: Who produces interferon in lupus?","volume":"13","author":"Decker","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Infante, B., Mercuri, S., Dello Strologo, A., Franzin, R., Catalano, V., Troise, D., Cataldo, E., Pontrelli, P., Alfieri, C., and Binda, V. (2022). Unraveling the Link between Interferon-\u03b1 and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415998"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41467-023-36522-z","article-title":"Oxidized mitochondrial DNA induces gasdermin D oligomerization in systemic lupus erythematosus","volume":"14","author":"Miao","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Reshetnyak, T., and Nurbaeva, K. (2023). The Role of Neutrophil Extracellular Traps (NETs) in the Pathogenesis of Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713581"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.celrep.2018.09.001","article-title":"IFN\u03b1 Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion","volume":"25","author":"Gkirtzimanaki","year":"2018","journal-title":"Cell Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/eci.12.106","article-title":"Fueling autoimmunity: Type I interferon in autoimmune diseases","volume":"9","author":"Cao","year":"2013","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Sharma, M., and de Alba, E. (2021). Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020872"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/hsw\/hlaa003","article-title":"Police Violence among Adults Diagnosed with Mental Disorders","volume":"45","author":"Jun","year":"2020","journal-title":"Health Soc. Work"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.4049\/jimmunol.1202388","article-title":"Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages","volume":"190","author":"Kahlenberg","year":"2013","journal-title":"J. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1194\/jlr.S091280","article-title":"Inflammasomes, neutrophil extracellular traps, and cholesterol","volume":"60","author":"Tall","year":"2019","journal-title":"J. Lipid Res."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Liu, Y., Tao, X., and Tao, J. (2022). Strategies of Targeting Inflammasome in the Treatment of Systemic Lupus Erythematosus. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.894847"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/BOR.0000000000000088","article-title":"The inflammasome and lupus: Another innate immune mechanism contributing to disease pathogenesis?","volume":"26","author":"Kahlenberg","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/2040622310380100","article-title":"Contemporary treatment of systemic lupus erythematosus: An update for clinicians","volume":"1","author":"Gordon","year":"2010","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: One drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"key":"ref_68","first-page":"1069","article-title":"Mechanistic target of rapamycin inhibitors: Successes and challenges as cancer therapeutics","volume":"2","author":"Bhaoighill","year":"2019","journal-title":"Cancer Drug Resist."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Sig. Transduct. Target Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1007\/s11033-023-08283-x","article-title":"Molecular and therapeutic insights of rapamycin: A multi-faceted drug from Streptomyces hygroscopicus","volume":"50","author":"Ganesh","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1759720X20953336","DOI":"10.1177\/1759720X20953336","article-title":"Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: A real-world study and meta-analysis","volume":"12","author":"Peng","year":"2020","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"108781","DOI":"10.1016\/j.clim.2021.108781","article-title":"Improvement of renal and non-renal SLE outcome measures on sirolimus therapy\u2014A 21-year follow-up study of 73 patients","volume":"229","author":"Piranavan","year":"2021","journal-title":"Clin. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e001072","DOI":"10.1136\/lupus-2023-001072","article-title":"Add-on sirolimus for the treatment of mild or moderate systemic lupus erythematosus via T lymphocyte subsets balance","volume":"11","author":"Ding","year":"2024","journal-title":"Lupus Sci. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s42358-024-00386-8","article-title":"II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment","volume":"64","author":"Seguro","year":"2024","journal-title":"Adv. Rheumatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3904\/kjim.2020.240","article-title":"Reduction in proteinuria after immunosuppressive therapy and long-term kidney outcomes in patients with immunoglobulin A nephropathy","volume":"36","author":"Kang","year":"2021","journal-title":"Korean J. Intern. Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Yung, S., and Chan, T.M. (2015). Mechanisms of Kidney Injury in Lupus Nephritis\u2014The Role of Anti-dsDNA Antibodies. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00475"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Chan, J., Walters, G.D., Puri, P., and Jiang, S.H. (2023). Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE). BMC Rheumatol., 7.","DOI":"10.1186\/s41927-023-00358-3"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/toxsci\/kfq364","article-title":"The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis","volume":"120","author":"Zhang","year":"2011","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4161\/cbt.9.2.10583","article-title":"N-acetylcysteine, reactive oxygen species and beyond","volume":"9","author":"Sun","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ten\u00f3rio, M.C.D.S., Graciliano, N.G., Moura, F.A., Oliveira, A.C.M., and Goulart, M.O.F. (2021). N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants, 10.","DOI":"10.3390\/antiox10060967"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Sahasrabudhe, S.A., Terluk, M.R., and Kartha, R.V. (2023). N-acetylcysteine Pharmacology and Applications in Rare Diseases-Repurposing an Old Antioxidant. Antioxidants, 12.","DOI":"10.3390\/antiox12071316"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/ars.2013.5702","article-title":"Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus","volume":"21","author":"Doherty","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e00010","DOI":"10.1097\/IN9.0000000000000010","article-title":"Principles behind SLE treatment with N-acetylcysteine","volume":"4","author":"Nasr","year":"2022","journal-title":"Immunometabolism"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"9949453","DOI":"10.1155\/2021\/9949453","article-title":"N-Acetylcysteine: A Review of Clinical Usefulness (an Old Drug with New Tricks)","volume":"2021","author":"Schwalfenberg","year":"2021","journal-title":"J. Nutr. Metab."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Zheng, H., Liu, J., Sun, L., and Meng, Z. (2024). The role of N-acetylcysteine in osteogenic microenvironment for bone tissue engineering. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1435125"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Su\u00e1rez-Rivero, J.M., Pastor-Maldonado, C.J., Povea-Cabello, S., \u00c1lvarez-C\u00f3rdoba, M., Villal\u00f3n-Garc\u00eda, I., Munuera-Cabeza, M., Su\u00e1rez-Carrillo, A., Talaver\u00f3n-Rey, M., and S\u00e1nchez-Alc\u00e1zar, J.A. (2021). Coenzyme Q10 Analogues: Benefits and Challenges for Therapeutics. Antioxidants, 10.","DOI":"10.3390\/antiox10020236"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Pallotti, F., Bergamini, C., Lamperti, C., and Fato, R. (2021). The Roles of Coenzyme Q in Disease: Direct and Indirect Involvement in Cellular Functions. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010128"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00421-020-04396-4","article-title":"MitoQ and CoQ10 supplementation mildly suppresses skeletal muscle mitochondrial hydrogen peroxide levels without impacting mitochondrial function in middle-aged men","volume":"120","author":"Pham","year":"2020","journal-title":"Eur. J. Appl. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Lee, R., Lee, W.Y., and Park, H.J. (2024). Anticancer Effects of Mitoquinone via Cell Cycle Arrest and Apoptosis in Canine Mammary Gland Tumor Cells. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25094923"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Pedrera, C., Villalba, J.M., Pati\u00f1o-Trives, A.M., Luque-T\u00e9var, M., Barbarroja, N., Aguirre, M.\u00c1., Escudero-Contreras, A., and P\u00e9rez-S\u00e1nchez, C. (2021). Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases. Antioxidants, 10.","DOI":"10.3390\/antiox10040600"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/art.41128","article-title":"Improved Mitochondrial Metabolism and Reduced Inflammation Following Attenuation of Murine Lupus With Coenzyme Q10 Analog Idebenone","volume":"72","author":"Blanco","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Gutierrez-Mariscal, F.M., Arenas-de Larriva, A.P., Limia-Perez, L., Romero-Cabrera, J.L., Yubero-Serrano, E.M., and L\u00f3pez-Miranda, J. (2020). Coenzyme Q10 Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217870"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Mantle, D., and Hargreaves, I.P. (2024). Coenzyme Q10 and Autoimmune Disorders: An Overview. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084576"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e001114","DOI":"10.1136\/lupus-2023-001114","article-title":"Clinical trial outcomes for SLE: What we have and what we need","volume":"11","author":"Arnaud","year":"2024","journal-title":"Lupus Sci. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e000239","DOI":"10.1136\/lupus-2017-000239","article-title":"Current and future therapies for SLE: Obstacles and recommendations for the development of novel treatments","volume":"4","author":"Touma","year":"2017","journal-title":"Lupus Sci. Med."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Tan, M.K.X., Heng, T.Y.J., and Mak, A. (2019). The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus. Cells, 8.","DOI":"10.3390\/cells8040323"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/acr2.11698","article-title":"Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis","volume":"6","author":"Lo","year":"2024","journal-title":"ACR Open Rheumatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","article-title":"Metformin Suppresses Systemic Autoimmunity in Roquinsan\/san Mice through Inhibiting B Cell Differentiation into Plasma Cells via Regulation of AMPK\/mTOR\/STAT3","volume":"198","author":"Lee","year":"2017","journal-title":"J. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Plowman, T.J., Christensen, H., Aiges, M., Fernandez, E., Shah, M.H., and Ramana, K.V. (2024). Anti-Inflammatory Potential of the Anti-Diabetic Drug Metformin in the Prevention of Inflammatory Complications and Infectious Diseases Including COVID-19: A Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105190"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Nojima, I., and Wada, J. (2023). Metformin and Its Immune-Mediated Effects in Various Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010755"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e000429","DOI":"10.1136\/lupus-2020-000429","article-title":"Effects of metformin on disease flares in patients with systemic lupus erythematosus: Post hoc analyses from two randomised trials","volume":"7","author":"Sun","year":"2020","journal-title":"Lupus Sci. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1759720X211073001","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: Overview of current knowledge","volume":"14","author":"Dima","year":"2022","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s40744-020-00212-9","article-title":"Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New","volume":"7","author":"Basta","year":"2020","journal-title":"Rheumatol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Echavarria, R., Cardona-Mu\u00f1oz, E.G., Ortiz-Lazareno, P., Andrade-Sierra, J., G\u00f3mez-Hermosillo, L.F., Casillas-Moreno, J., Campos-Bayardo, T.I., Rom\u00e1n-Rojas, D., Garc\u00eda-S\u00e1nchez, A., and Miranda-D\u00edaz, A.G. (2023). The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242015234"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Jing, W., Liu, C., Su, C., Liu, L., Chen, P., Li, X., Zhang, X., Yuan, B., Wang, H., and Du, X. (2023). Role of reactive oxygen species and mitochondrial damage in rheumatoid arthritis and targeted drugs. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1107670"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Liu, Y., Li, Y., Xue, L., Xiao, J., Li, P., Xue, W., Li, C., Guo, H., and Chen, Y. (2022). The effect of the cyclic GMP-AMP synthase-stimulator of interferon genes signaling pathway on organ inflammatory injury and fibrosis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1033982"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: From malaria to autoimmunity","volume":"42","author":"Kivity","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Niemann, B., Puleo, A., Stout, C., Markel, J., and Boone, B.A. (2022). Biologic Functions of Hydroxychloroquine in Disease: From COVID-19 to Cancer. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122551"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Brant, E.J., Rietman, E.A., Klement, G.L., Cavaglia, M., and Tuszynski, J.A. (2020). Personalized therapy design for systemic lupus erythematosus based on the analysis of protein-protein interaction networks. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0226883"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00431-008-0740-z","article-title":"Rab proteins and Rab-associated proteins: Major actors in the mechanism of protein-trafficking disorders","volume":"167","author":"Corbeel","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"244","DOI":"10.23876\/j.krcp.20.082","article-title":"Mitochondrial dysfunction in kidney injury, inflammation, and disease: Potential therapeutic approaches","volume":"39","author":"Bhatia","year":"2020","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bcp.12104","article-title":"Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease","volume":"76","author":"Cravedi","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Choi, M.Y., and Costenbader, K.H. (2022). Understanding the Concept of Pre-Clinical Autoimmunity: Prediction and Prevention of Systemic Lupus Erythematosus: Identifying Risk Factors and Developing Strategies Against Disease Development. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.890522"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.molmed.2017.05.006","article-title":"Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective","volume":"23","author":"Moulton","year":"2017","journal-title":"Trends Mol. Med."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Karunakaran, U., Elumalai, S., Moon, J.S., and Won, K.C. (2021). Pioglitazone-induced AMPK-Glutaminase-1 prevents high glucose-induced pancreatic \u03b2-cell dysfunction by glutathione antioxidant system. Redox Biol., 45.","DOI":"10.1016\/j.redox.2021.102029"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/febs.13992","article-title":"Pioglitazone inhibits mitochondrial pyruvate metabolism and glucose production in hepatocytes","volume":"284","author":"Shannon","year":"2017","journal-title":"FEBS J."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Yang, S., Zhao, M., and Jia, S. (2023). Macrophage: Key player in the pathogenesis of autoimmune diseases. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1080310"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/ard-2022-222658","article-title":"Peroxisome proliferator activated receptor-\u03b3 agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus","volume":"81","author":"Hasni","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jacc.2008.04.055","article-title":"The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice","volume":"52","author":"Orasanu","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0961203311422096","article-title":"Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: A double-blind randomized clinical trial","volume":"21","author":"Silveira","year":"2012","journal-title":"Lupus"},{"key":"ref_121","first-page":"33","article-title":"The Role of NETosis in Systemic Lupus Erythematosus","volume":"1","author":"Salemme","year":"2019","journal-title":"J. Cell. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Pannu, N., and Bhatnagar, A. (2020). Oxidative stress and immune complexes: Pathogenic mechanisms in pristane induced murine model of lupus. Immunobiology, 225.","DOI":"10.1016\/j.imbio.2019.11.006"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13075-018-1749-y","article-title":"Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation","volume":"20","author":"Liao","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41419-020-2547-4","article-title":"Nestin protects podocyte from injury in lupus nephritis by mitophagy and oxidative stress","volume":"11","author":"Tian","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"R1761","DOI":"10.1152\/ajpregu.00319.2006","article-title":"Expression of nestin in the podocytes of normal and diseased human kidneys","volume":"292","author":"Su","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/15548627.2019.1580512","article-title":"Podocytes and autophagy: A potential therapeutic target in lupus nephritis","volume":"15","author":"Zhou","year":"2019","journal-title":"Autophagy"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Halfon, M., Tankeu, A.T., and Ribi, C. (2024). Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25116162"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/12\/9\/226\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:00:48Z","timestamp":1760112048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/12\/9\/226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":127,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["diseases12090226"],"URL":"https:\/\/doi.org\/10.3390\/diseases12090226","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}